The MC Hospital of the President’s Affairs Administration of the Republic of Kazakhstan is the only medical institution in Kazakhstan that conducts PET studies using 7 different radiopharmaceuticals

PET/CT (positron emission tomography combined with computed tomography) is one of the most advanced hybrid diagnostic methods in oncology, which allows you to “see the invisible”. This combination of two powerful technologies: PET and CT, makes it possible to look inside the body with unprecedented accuracy and identify diseases at an early stage, even when they do not yet show obvious symptoms.

PET/CT helps to detect tumors at those stages when they are just beginning to develop. This is especially important for oncological diseases, where early detection can save lives. This method allows you not only to see the primary tumor, but also to assess whether there are metastases - cancer cells that have spread throughout the body.

PET/CT is also used to monitor the tumor's response to treatment, allowing the doctor to promptly adjust tactics if standard treatment does not bring the expected results. PET/CT can show whether the disease has returned after treatment has been completed, allowing for re-therapy to be started at the earliest stages.

The procedure is completely non-invasive and painless for the patient, making it a convenient and safe diagnostic technique.

If you require detailed diagnostics, PET/CT can be an important step towards proper treatment and recovery.

The Nuclear Medicine Center of the MC Hospital of the President’s Affairs Administration of the Republic of Kazakhstan conducts all types of radioisotope studies (scintigraphy, BFECT/CT, PET/CT), it is important to note that the Medical Center Hospital is the only Center in Kazakhstan that conducts PET studies with 7 different radiopharmaceuticals.